Lam Research Corp (LRCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,256,499 | 3,522,001 | 4,194,719 | 5,086,544 | 4,042,151 |
| Marketable Securities | 120,551 | 135,731 | 160,072 | 242,590 | 569,472 |
| Receivables | 4,569,735 | 4,313,818 | 3,702,320 | 3,402,840 | 3,397,180 |
| Inventories | 4,360,325 | 3,966,294 | 3,479,332 | 3,074,177 | 2,872,141 |
| Other current assets | -4 | 5 | -1 | -2 | -2 |
| TOTAL | $13,612,660 | $12,285,240 | $11,888,100 | $12,102,860 | $11,144,680 |
| Non-Current Assets | |||||
| PPE Net | 1,718,791 | 1,647,587 | 1,561,875 | 1,503,385 | 1,372,533 |
| Intangibles | 1,624,932 | 1,616,963 | 1,627,035 | 1,601,755 | 1,614,959 |
| Other Non-Current Assets | 1,764,895 | 1,645,847 | 1,512,020 | 1,477,426 | 1,433,378 |
| TOTAL | $5,108,618 | $4,910,397 | $4,700,930 | $4,582,566 | $4,420,870 |
| Total Assets | $18,721,280 | $17,195,630 | $16,589,030 | $16,685,430 | $15,565,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,110 | 7,381 | 7,689 | 6,201 | 6,368 |
| Accounts payable and accrued liabilities | 1,146,286 | 1,011,208 | 1,007,026 | 952,666 | 837,708 |
| Accrued Expenses | 1,948,776 | 1,974,272 | 1,634,917 | 1,770,406 | 1,633,729 |
| TOTAL | $5,053,382 | $4,564,759 | $4,194,741 | $3,863,151 | $3,409,220 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,996,363 | 4,998,449 | 5,000,657 | 4,988,121 | 4,988,964 |
| Deferred Revenues | 1,951,210 | 1,571,898 | 1,545,109 | 1,133,878 | 931,415 |
| Other Non-Current Liabilities | 1,258,970 | 1,354,058 | 1,367,143 | 1,358,375 | 1,347,325 |
| TOTAL | $6,255,333 | $6,352,507 | $6,367,800 | $6,346,496 | $6,336,289 |
| Total Liabilities | $11,308,710 | $10,917,270 | $10,562,540 | $10,209,650 | $9,745,509 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,363,793 | 1,369,878 | 1,387,150 | 1,395,001 | 1,407,987 |
| Common Shares | 136 | 137 | 139 | 140 | 141 |
| Retained earnings | 19,644,620 | 18,454,720 | 17,451,400 | 16,637,680 | 15,653,440 |
| Other shareholders' equity | -134,011 | -110,407 | -97,442 | -88,398 | -81,341 |
| TOTAL | $7,412,567 | $6,278,366 | $6,026,490 | $6,475,781 | $5,820,043 |
| Total Liabilities And Equity | $18,721,277 | $17,195,636 | $16,589,030 | $16,685,431 | $15,565,552 |